HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF
January 20, 2003
- WEBSITE NEWS
January 20, 2003
- Editorial Policy for New Edition of JP Announced
January 20, 2003
- Arixtra Shows Same Results as Standard Treatment for Venous Thromboembolism
January 20, 2003
- Korosho Starts Full-scale Preparations for New Drug Organization
January 20, 2003
- Merck & Co to Get Full Ownership of Banyu via TOB
January 20, 2003
- Korosho to Hold "Direct Dialogue" with Stakeholders on Basic Reform Policy
January 20, 2003
- Over Half of Major Drugs Saw Lower Sales in 1st Half: Top 102 Products Survey
January 20, 2003
-
January 20, 2003
- 8 Top Domestic Makers Have Similar Numbers of MRs But Different Strategies
January 20, 2003
- REGULATORY NEWS IN BRIEF
January 20, 2003
- Govt's Industry Policies to Start in Earnest in 2003: Mr Nagayama
January 20, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 20, 2003
- New Year's Party Sees Great Expectations of Pharma Industry
January 20, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
January 20, 2003
- Leaders Determined to Tackle Problems in 2003: New Year Addresses
January 20, 2003
- Making 2003 "Epoch-making Year" for Self-medication: OTC Direct Selling Maker Leaders
January 20, 2003
- Rapid Response to Market Changes Crucial: Mr Matsutani of Toho
January 20, 2003
- Ain Pharmaciez: Operating Profits Up 44%
January 20, 2003
- JPMA Aims for NHI Prices in Line with Value
January 20, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
